Laurie Saloman, MS

A study demonstrated patients were frequently prescribed broad-spectrum antibiotics when more narrowly tailored antibiotics were considered the optimal choice.

A single dose of pegylated lambda-interferon delivered within a week of the start of COVID-19 symptoms appears to significantly reduce the likelihood that a patient will end up hospitalized from the disease.

Sky-high costs with little wiggle room to negotiate mean fidaxomicin remains underprescribed for recurrent C diff, despite favorable outcomes.

Although medical masks were noninferior to N95 in a multinational study of frontline health care workers, variability in circumstances between countries prevented researchers from drawing firm conclusions.

A deep dive into the number of deaths from COVID-19 and other causes reveals a significant disparity between the US and its peer nations.

An easy-to-administer oral biologic kept repeat C difficile infections at bay in a new study.

With proper treatment, even the youngest sufferers can recover. Know the signs when treating potentially infected children, especially if they have environmental risk factors.

As greenhouse gas emissions result in floods, heat waves, and more extreme weather events, people and pathogens are thrown closer together.

A new study found that patients hospitalized with COVID-19 are at significantly higher risk for venous thromboembolism in the ensuing 3 months than are patients hospitalized with influenza.

Durable immune responses are seen in all age groups, even with significant discrepancies in antibody levels between children and adults.

With antimicrobial resistance a rising threat, the World Health Organization is working to heighten awareness of the urgent need for new therapies.

What are the impacts of COVID-19 and other respiratory-based diseases on neurological processes? A new observational study assesses the likelihood of Alzheimer’s, Parkinson’s, and stroke in people who contract COVID-19 as well as influenza and pneumonia.

The stress of enduring an infectious disease pandemic expresses itself in a variety of mental health conditions, but the likelihood of experiencing particular symptoms depends on who you are.

Immunization against COVID-19 benefits pregnant women as well as their offspring.

Available literature on thrombosis occurrence in COVID-19 patients focuses on hospitalized cases. A new study sheds light on the incidence of thromboembolism in less severe cases of disease,

Data on hospitalizations of children during the pandemic highlighted the seriousness of MIS-C, particularly in children of color.

Antibiotic overuse is a longstanding problem in the medical community. A new study highlights the benefits of accurate point-of-care testing to differentiate between bacteria and viruses.

A shorter dosing period and no extra risk of suffering acute myocardial infarction means the newer 2-dose hepatitis B vaccine is an attractive option for protection.

The public health policies enacted in republican and democratic states have never been more different, and the gulf shows no signs of narrowing.

Popular pain and fever-reducing drugs can have unintended consequences when it comes to infectious diseases.

The waning of protection after full vaccination matters more than the advent of the more transmissible Delta variant in subjects who tested positive for COVID-19.

Not all people unvaccinated against COVID-19 people are actively avoiding the vaccine. A new study shows that Black people were vaccinated at lower rates than White people in the US early on, even after they indicated they were willing to get the shot. The study’s authors explain the reasons behind this.

Backed by solid data, clinicians can work to overcome vaccine hesitancy due to fears about negative pregnancy outcomes.

For already-vulnerable cancer patients, a COVID-19 diagnosis is especially concerning. A new study reveals that when it comes to disease outcomes, geographical location is not a factor—but individual cancer centers can make a difference.

Immigrant communities may be more hesitant to disclose personal health information due to fears of bullying or deportation, a new study finds.

Planning travel and social gatherings as Omicron gathers steam requires extra preparation and a degree of flexibility.

New research reveals that women who test positive for COVID-19 at the time they give birth pass along antibodies in breast milk, protecting their newborns from infection

COVID-19 testing has been an integral part of our country’s strategy to limit disease transmission. Here’s the latest information on types of tests, when they’re appropriate to use, and what they realistically can and cannot do to curb infection.

The federal agency and infectious disease organization have teamed up to offer a wealth of resources for health care professionals on the frontlines of treating the virus.

The National Foundation for Infectious Diseases (NFID) recently sponsored a media briefing addressing the risks of contracting influenza and pneumococcal disease in the midst of a still-flourishing COVID-19 pandemic.